In neuropathic conditions, the PPARα agonists GW7647 and palmitoylethanolamide (PEA) managed to attenuate hyperalgesia, whereas these actions were absent in PPARα knock-out neuropathic pain mice [63]. Here, PPARA is linked to neuropathic pain.